DMK
CNCE

David M. Knott’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

David M. Knott’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-83,607
Closed -$1.01M – 120
2019
Q1 		$1.01M Buy
83,607
+3,307
+4% +$48.7K 0.4% 45
2018
Q4 		$1.01M Buy
80,300
+14,300
+22% +$197K 0.47% 40
2018
Q3 		$979K Buy
66,000
+14,443
+28% +$227K 0.32% 44
2018
Q2 		$868K Buy
51,557
+2,000
+4% +$38.8K 0.33% 48
2018
Q1 		$1.14M Hold
49,557
– – 0.47% 29
2017
Q4 		$1.28M Buy
49,557
+4,557
+10% +$91.8K 0.51% 22
2017
Q3 		$664K Buy
+45,000
New +$653K 0.28% 46

Other funds holding CNCE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

David M. Knott's CNCE Position: Q2 2019 in Review

David M. Knott sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2019, closing a stake of 83,607 shares — an estimated $1.01M sold.

David M. Knott first reported a position in CNCE in Q3 2017 and held it in 7 quarters. The position peaked at $1.28M in Q4 2017. 87 funds tracked by Wall St. Rank hold CNCE as of Q2 2019.

  • David M. Knott reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • David M. Knott sold 83,607 Concert Pharmaceuticals, Inc. shares in Q2 2019, an estimated $1.01M.
  • David M. Knott first reported a position in Concert Pharmaceuticals, Inc. in Q3 2017 and held it in 7 quarters.
  • David M. Knott's Concert Pharmaceuticals, Inc. position peaked at $1.28M in Q4 2017.
  • 87 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2019.

Based on David M. Knott's 13F filing for Q2 2019, filed 12 Aug 2019.